OpenAI has opened preliminary talks about handing the U.S. government a 5% stake in the company, worth roughly $42.6 billion against the $852 billion post-money valuation set in March’s record funding round. The Financial Times reported the discussions on July 2, citing two people familiar with the matter. Sam Altman is understood to have raised the idea directly with Donald Trump, Commerce Secretary Howard Lutnick, and Treasury Secretary Scott Bessent.

The timing is the story. Six days earlier, Lutnick had reportedly warned Altman against releasing GPT-5.6 without prior approval, and OpenAI duly delayed the full public launch. Through most of June, Anthropic’s Claude Fable 5 and Mythos 5 sat disabled worldwide under the first U.S. export controls ever applied to an AI model rather than a chip. Access was restored on July 1. On July 2, Altman’s equity pitch surfaced.

Altman’s proposal doesn’t stop at OpenAI. He’s floated a broader vehicle in which every leading U.S. AI developer contributes a 5% equity share, modeled loosely on the Alaska Permanent Fund. Google, Meta, and Anthropic haven’t indicated they’d participate, and a source told CNBC the Trump administration hasn’t discussed taking stakes in Anthropic at all.

There’s a political flank here too. Altman has also held conversations with Bernie Sanders, whose American AI Sovereign Wealth Fund Act, filed in June, would demand 50% of voting shares from U.S. AI companies, a vehicle Sanders’ office pegs at $7 trillion and pays out as a $1,000 annual dividend per American. Altman’s 5% is, functionally, a counter-offer.

The template is already in motion. Washington took a 10% stake in Intel after an $8.9 billion common-stock investment; AMD and Nvidia agreed to hand over 15% of China AI chip revenue. Trump has called the emerging arrangement “a beautiful thing” that would make Americans “partners in this revolution.”

Indranil Bandyopadhyay of Forrester warned it could invite “other jurisdictions to demand analogous arrangements.” That’s the quiet part. A frontier lab pre-emptively offering equity to avoid a launch veto is a governance regime, not a funding round. The FT notes any deal might require an act of Congress. The pricing has already happened.

Sources